ArticleAMB Express2018
Biological conversion of aromatic monolignol compounds by a Pseudomonas isolate from sediments of the Baltic Sea.
Article in AMB Express, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Unlocking the biotechnological potential of Baltic microorganisms.Frontiers in microbiology · 2025Review
- Enterobacter spp. isolates from an underground coal mine reveal ligninolytic activity.BMC microbiology · 2024Article
- Four NovelViruses · 2023Article
- Screening and evaluation of skin potential probiotic from high-altitude Tibetans to repair ultraviolet radiation damage.Frontiers in microbiology · 2023Article
- Looking into the world's largest elephant population in search of ligninolytic microorganisms for biorefineries: a mini-review.Biotechnology for biofuels and bioproducts · 2022Review
- Low-Temperature Biodegradation of Lignin-Derived Aromatic Model Monomers by the Cold-Adapted YeastMicroorganisms · 2022Article
- A novel Bacillus ligniniphilus catechol 2,3-dioxygenase shows unique substrate preference and metal requirement.Scientific reports · 2021Article
- Biodegradation of lignin monomers and bioconversion of ferulic acid to vanillic acid by Paraburkholderia aromaticivorans AR20-38 isolated from Alpine forest soil.Applied microbiology and biotechnology · 2021Article
- Vanillin Production inApplied and environmental microbiology · 2020Article
- Mapping the diversity of microbial lignin catabolism: experiences from the eLignin database.Applied microbiology and biotechnology · 2019Review
- Genomic analysis ofBiotechnology for biofuels · 2019Article
- Recent advances in lignin valorization with bacterial cultures: microorganisms, metabolic pathways, and bio-products.Biotechnology for biofuels · 2019Review
- Bacterial conversion of depolymerized Kraft lignin.Biotechnology for biofuels · 2019Article
- Bacterial conversion of depolymerized Kraft lignin.Biotechnology for biofuels · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bacterial strains were isolated from the sediments of the Baltic Sea using ferulic acid, guaiacol or a lignin-rich softwood waste stream as substrate. In total nine isolates were obtained, five on ferulic acid, two on guaiacol and two on a lignin-rich softwood stream as a carbon source. Three of the isolates were found to be Pseudomonas sp. based on 16S rRNA sequencing. Among them, isolate 9.1, which showed the fastest growth in defined M9 medium, was tentatively identified as a Pseudomonas deceptionensis strain based on the gyrB sequencing. The growth of isolate 9.1 was further examined on six selected lignin model compounds (ferulate, p-coumarate, benzoate, syringate, vanillin and guaiacol) from different upper funneling aromatic pathways and was found able to grow on four out of these six compounds. No growth was detected on syringate and guaiacol. The highest specific growth and uptake rates were observed for benzoate (0.3 h
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.